Top 10 Life Science Angel Investors in Belgium (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Luc Vauterin
Angel
|
2 | Belgium | Seed, Series A | Life Science, Data Integration, Data Visualization | |
|
Annie Vereecken
Angel
|
2 | Belgium | Seed, Series A | Medical, Biotechnology, Hospital | $2M–$27M |
|
Pierre Drion
Angel
|
2 | Belgium | Series A, Series B | Biotechnology, Health Care, Life Science | $8.8M–$26M |
|
Kenneth Buckfire
Angel
|
1 | Belgium | Series A | Medical, Health Care, Life Science | |
|
Evren Ucok
Angel
|
1 | Turkey, Belgium | Series A | Medical, Health Care, Life Science | |
|
Piet Van Waes
Angel
|
1 | Belgium | Seed, Pre-Seed | Hotel, Medical, Tourism | $1M–$2.4M |
|
Virginie Saverys
Angel
|
1 | Belgium | Seed | Medical, Life Science, Biotechnology | |
|
Annemie Van de Casteele
Angel
|
1 | Belgium | Seed | Medical, Life Science, Biotechnology | |
|
Griet Nuytinck
Angel
|
1 | Belgium | Seed | Medical, Life Science, Biotechnology | |
|
Jürgen Ingels
Angel
|
1 | Belgium, Turkey, The Netherlands | Seed, Series B, Series A | Software, Analytics, SaaS | $2.4M–$35M |
| Access all 10 angel investors in Belgium Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Luc Vauterin - Board Member @ ONTOFORCE
Show more...Investment focus
- Industry: Life Science, Data Integration, Data Visualization
- Stage:Seed, Series A
- Geography: Belgium
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- ONTOFORCE — ONTOFORCE creates and implements pioneering semantic search technology for information management. Our user-friendly data search platform DISQOVER builds uniquely intelligent links between heterogeneous data sources, allowing everybody to become a data scientist.
Annie Vereecken
Show more...Investment focus
- Industry: Medical, Biotechnology, Hospital
- Stage:Seed, Series A
- Geography: Belgium
Investor stats
- Total investments: 7
- Round size: Seed $2M–$6M; Series A $8.2M–$27M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
- Sensolus — Sensolus provides care-free tracking of your valuable non-powered assets directly from the cloud.Sensolus offers turnkey solutions for wireless, low-power context-aware sensing. Sensolus developed a personal product line of low-power tracker systems called STICKNTRACK.Sensolus is built upon many years of expertise in low-power networks,wireless sensor design, cloud-based sensor management, analytics, and applications.
- Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Pierre Drion - CEO @ Petercam
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Series B
- Geography: Belgium
Investor stats
- Total investments: 5
- Round size: Series A $8.8M–$14M; Series B $18M–$26M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
- Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
- Santero Therapeutics — This is the homepage of the website
Kenneth Buckfire is the Chief Executive Officer at Miller Buckfire.
Show more...Investment focus
- Industry: Medical, Health Care, Life Science
- Stage:Series A
- Geography: Belgium
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Evren Ucok is a co-founder and investor at Peak Games, an interactive social game development platform. He is also a partner at Earlybird Venture Capital, an investment fund-based in Europe that focuses on emerging companies; Trendyol.com, a fashion e-commerce site; and Oliver Wyman.
Show more...Investment focus
- Industry: Medical, Health Care, Life Science
- Stage:Series A
- Geography: Turkey, Belgium
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- idemama — Idemama is an online platform that provides its users with web and graphic design services. It is based in Istanbul, Turkey.
- Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Piet Van Waes is the Managing Director and Founder of Tilleghem. He previously worked at Green Park Investment Partners as a Partner. Piet Van Waes attended KU Leuven.
Show more...Investment focus
- Industry: Hotel, Medical, Tourism
- Stage:Seed, Pre-Seed
- Geography: Belgium
Investor stats
- Total investments: 4
- Round size: Seed $1M–$2.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Rookoo — Rookoo is an AI-driven venue management software that talks to your customers, handles the intake, checks availability, fills your CRM or booking software, and hands off to your team for seamless follow-up.
- Tinrate — Tinrate is an easy-to-use connection that allows instructors, experts, and artists to be booked and paid immediately for their services. It serves as a link between your audience and your bank account rather than being a platform full of
- Exhibitly.ai — Exhibitly.ai provides an AI‑powered platform for trade shows and B2B conferences that personalizes visitor experiences on event websites. Generates tailored exhibitor and session recommendations using attendee job title and company inputs. Converts anonymous website traffic into higher‑intent leads for event organizers.
Virginie Saverys is a entrepreneur.
Show more...Investment focus
- Industry: Medical, Life Science, Biotechnology
- Stage:Seed
- Geography: Belgium
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Annemie Van de Casteele is a former member of the Belgian Parliament.
Show more...Investment focus
- Industry: Medical, Life Science, Biotechnology
- Stage:Seed
- Geography: Belgium
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Griet Nuytinck is founder of Anacura.
Show more...Investment focus
- Industry: Medical, Life Science, Biotechnology
- Stage:Seed
- Geography: Belgium
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Jurgen Ingels is the Founder and Managing Partner of SmartFin. He previously worked at FTI SuperNova as an Organizer. Jurgen holds a Master's degree in Political and Social Sciences and an MBA from the University of Antwerp.
Show more...Investment focus
- Industry: Software, Analytics, SaaS
- Stage:Seed, Series B, Series A
- Geography: Belgium, Turkey, The Netherlands
Investor stats
- Total investments: 18
- Round size: Seed $2.4M–$3M; Series A $3.3M–$12M; Series B $5.3M–$35M
- Lead/follow: 61% lead, 39% follow
Portfolio highlights
- Auditstage —
- Casper — Casper is a pan European Hybrid Kitchen pioneer and a modern day food hall; 100% virtual and getting everyone what they want. Their vision is to have a foothold in every great city of Europe: a virtual food hall (referring to the wide variety of cuisines available from which you can order) at everyone’s fingertips, from the comfort of their ownhome. Available for in-store purchase, pick-up or within 30 minutes delivery distance. Similar to a dark kitchen, Casper's kitchen operations are takeaway & delivery focused. However, they differ by choosing high street locations where customers are able to walk in and order from a kiosk, click & collect or pick-up from the deli. While they wait for and see how their food is prepared, the branded in-store environment allows them to engage with the brand; completely wiping out the mystery-factor and all misconceptions around ghost kitchens.
- Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Life Science Angel investor funding in Belgium at a glance
Stats across 10 deals from 10 investors.
Access all 10 angel investors in Belgium Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Angel Investors in Belgium investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 10 angel investors investing in Belgium Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!